Antibody Drugs Market size is estimated to reach $139.82bn by 2025, growing at a CAGR of 6.5% during the forecast period 2020-2025. An antibody is a Y shaped protein built by the plasma cells and is used by the immune system to neutralize the harmful bacteria and viruses in the body. Antibody drugs are the medicines that are used to destroy the disease causing elements in the body. These antibody drugs are used to treat diseases like different types of infections, allergies, cancers and others. Increase funding by the government and private sectors, rising health awareness are some of the factors that are driving the growth of the market during the forecast period 2020-2025.
By Drug Type – Segment Analysis
The Drug Type segment of the Antibody Drugs Market has Monoclonal antibodies, Antibody-drug conjugates, and Polyclonal antibodies. The Monoclonal antibodies segment registers for the highest market share in 2019 and is set to continue for the forecast period 2020-2025. These monoclonal antibodies provide a good immune system to fight the antigens like viruses, bacteria, parasites fungi and others. Antibody-drug conjugates segment is also set to have healthy growth, as they are helpful in the treatment of cancers by killing tumor cells while protecting healthy cells. Growing health issues among the people and increased health care facilities are driving the usage of antibody drugs during the forecast period 2020-2025.
Request for Sample of the Report @ https://www.industryarc.com/pdfdownload.php?id=15697
Report Price: $ 4500 (Single User License)
By Application – Segment Analysis
The Application segment of the Antibody Drugs Market has the Central nervous system, Cancers, Autoimmune disorders and cardiovascular diseases, and others. The Autoimmune disorders segment registers for the highest market share in 2019 and is set to continue for the forecast period 2020-2025, owing to the increased number of people suffering from different types of autoimmune disorders, and there are over 80 types of autoimmune disorder with symptoms like low-grade fever and tiredness. The cancer segment is also set to have the fastest growth owing to the increased number of cancer patients globally. The development of new drugs for different types of diseases and increased funding by both public and private companies are driving the market during the forecast period 2020-2025.
By Geography – Segment Analysis
Based on Geography the global Antibody Drugs Market is segmented into North America, Europe, Asia-Pacific and the Rest of World. North America had a dominant share in terms of revenue in 2019 and it holds the largest market share during the forecast period 2020-2025, owing to the increased usage of Antibody Drugs. Asia-Pacific is also set to have the fastest growth owing to the increased population with different types of diseases. On the other hand, Europe is set to have healthy growth, owing to increased developments made by the manufacturers. Increased disposal income by the growing population and rising health issues like cancers, cardiovascular issues and other diseases is driving the growth of the market globally during the forecast period.
Drivers – Antibody Drugs Market
High prevalence of health issues
The increase in diseases like cancers, allergies, infections, and increased health care expenditure by the global population are driving the growth of the Antibody Drugs market during the forecast period 2020-2025.
Talk to one of our sales representative about the full report by providing your details in the link below:
Challenges – Antibody Drugs Market
High cost of drugs
The cost of the Antibody Drugs and lack of awareness among the people for using different types of diseases are challenging market. Side effects caused by the consumption of a few types of drugs are also hindering the growth of the market during the forecast period 2020-2025.
Antibody Drugs Industry outlook:
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Antibody Drugs Market. Key companies of this market are Biogen Inc, Johnson & Johnson, Novartis AG, Amgen Inc, AbbVie Inc, Seattle Genetics Inc, Roche Holdings, Merck & Co., ImmunoGen, Inc., Pfizer Inc., and others.
In June 2020, Biogen Inc., had announced the data of sixteen weeks cutaneous lupus erythematosus portion of phase two LILAC study, This study is done to check the efficiency of the BllB059, a fully humanized IgG1 monoclonal antibody (mAb) which is used for the treatment of blood dendritic cell antigen 2, which is expressed on plasmacytoid dendritic cells.
In April 2016, Pfizer company get approval from FDA for its Celltrion’s INFLECTRA, this Remicade INFLECVTRA is the first and only biosimilar monoclonal antibody and second one to be approved in the U.S. INFLECTRA is used in reducing symptoms in patients who are suffering from rheumatoid arthritis, ulcreative colitis, and other diseases.
Geographically, North America’s Antibody Drugs Market accounted for the highest revenue share in 2019 and it is poised to dominate during the forecast period 2020-2025 owing to the high disposal income and availability of a large number of manufacturers for Antibody Drugs.
The increase in health concerns and increased prevalence of diseases like cancers, cardiovascular issues, and other infections and allergies are driving the market for Antibody Drugs during the forecast period 2020-2025.
Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Antibody Drugs Market report.
Antibody drugs are the best alternative for the diseases where the treatment is not possible, and having less side effects and development of good immunity are driving the antibody drug market.
Related Reports :
A. Antibody Drug Conjugate Market
B. Antibody Testing Market
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to firstname.lastname@example.org to discuss more about our consulting services.